Cargando…

Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040

AIM: To estimate the potential cost of lost labour productivity due to cancer-related premature mortality in Europe (EU-27 plus Norway, Switzerland, Iceland and United Kingdom) from 2018 to 2040. METHODS: Deaths and years of potential productive life lost due to 23 types of cancer were estimated for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortega-Ortega, Marta, Hanly, Paul, Pearce, Alison, Soerjomataram, Isabelle, Sharp, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627946/
https://www.ncbi.nlm.nih.gov/pubmed/37552416
http://dx.doi.org/10.1007/s40258-023-00824-6
_version_ 1785131641499287552
author Ortega-Ortega, Marta
Hanly, Paul
Pearce, Alison
Soerjomataram, Isabelle
Sharp, Linda
author_facet Ortega-Ortega, Marta
Hanly, Paul
Pearce, Alison
Soerjomataram, Isabelle
Sharp, Linda
author_sort Ortega-Ortega, Marta
collection PubMed
description AIM: To estimate the potential cost of lost labour productivity due to cancer-related premature mortality in Europe (EU-27 plus Norway, Switzerland, Iceland and United Kingdom) from 2018 to 2040. METHODS: Deaths and years of potential productive life lost due to 23 types of cancer were estimated for 2018–2040, for 31 European countries. The data were analysed by age groups, by sex and by year. Projected productivity costs were estimated by calculating gross earnings by country, gender and age group using the Human Capital Approach, adjusting for projected labour force participation and unemployment rates. Various data sources were used. Sensitivity analyses were conducted. RESULTS: Between 2018 and 2040, cancer is expected to cause around eight million premature deaths (58% male). The cumulative projected productivity costs in this respect are €1.3 trillion, representing an annual average of €58.7 billion, or 0.43% of the EU-27 gross domestic product. Labour productivity costs are projected to decrease by 6% from 2018 to 2040. The highest cost region is Western Europe, where Germany and France will experience the highest cumulative losses (€288 and €192 billion, respectively). The most costly cancers, in terms of total costs related to productivity losses, are of the lung and colorectum (€264.4 and €116.3 billion, respectively). In terms of average productivity cost per death, the most costly forms of cancer are Hodgkin lymphoma (€301,157) and melanoma (€260,522). CONCLUSION: The novel information presented could help national policymakers anticipate possible areas for cost savings. Action should be taken on disease prevention, on reducing mortality and on delaying the age of death due to Hodgkin lymphoma, brain cancer, leukaemia and melanoma. Furthermore, the study findings enhance our understanding of macroeconomic variables and could be useful in determining a re-allocation of health expenditures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40258-023-00824-6.
format Online
Article
Text
id pubmed-10627946
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-106279462023-11-08 Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040 Ortega-Ortega, Marta Hanly, Paul Pearce, Alison Soerjomataram, Isabelle Sharp, Linda Appl Health Econ Health Policy Original Research Article AIM: To estimate the potential cost of lost labour productivity due to cancer-related premature mortality in Europe (EU-27 plus Norway, Switzerland, Iceland and United Kingdom) from 2018 to 2040. METHODS: Deaths and years of potential productive life lost due to 23 types of cancer were estimated for 2018–2040, for 31 European countries. The data were analysed by age groups, by sex and by year. Projected productivity costs were estimated by calculating gross earnings by country, gender and age group using the Human Capital Approach, adjusting for projected labour force participation and unemployment rates. Various data sources were used. Sensitivity analyses were conducted. RESULTS: Between 2018 and 2040, cancer is expected to cause around eight million premature deaths (58% male). The cumulative projected productivity costs in this respect are €1.3 trillion, representing an annual average of €58.7 billion, or 0.43% of the EU-27 gross domestic product. Labour productivity costs are projected to decrease by 6% from 2018 to 2040. The highest cost region is Western Europe, where Germany and France will experience the highest cumulative losses (€288 and €192 billion, respectively). The most costly cancers, in terms of total costs related to productivity losses, are of the lung and colorectum (€264.4 and €116.3 billion, respectively). In terms of average productivity cost per death, the most costly forms of cancer are Hodgkin lymphoma (€301,157) and melanoma (€260,522). CONCLUSION: The novel information presented could help national policymakers anticipate possible areas for cost savings. Action should be taken on disease prevention, on reducing mortality and on delaying the age of death due to Hodgkin lymphoma, brain cancer, leukaemia and melanoma. Furthermore, the study findings enhance our understanding of macroeconomic variables and could be useful in determining a re-allocation of health expenditures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40258-023-00824-6. Springer International Publishing 2023-08-08 2023 /pmc/articles/PMC10627946/ /pubmed/37552416 http://dx.doi.org/10.1007/s40258-023-00824-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research Article
Ortega-Ortega, Marta
Hanly, Paul
Pearce, Alison
Soerjomataram, Isabelle
Sharp, Linda
Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040
title Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040
title_full Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040
title_fullStr Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040
title_full_unstemmed Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040
title_short Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040
title_sort projected impact on labour productivity costs of cancer-related premature mortality in europe 2018–2040
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627946/
https://www.ncbi.nlm.nih.gov/pubmed/37552416
http://dx.doi.org/10.1007/s40258-023-00824-6
work_keys_str_mv AT ortegaortegamarta projectedimpactonlabourproductivitycostsofcancerrelatedprematuremortalityineurope20182040
AT hanlypaul projectedimpactonlabourproductivitycostsofcancerrelatedprematuremortalityineurope20182040
AT pearcealison projectedimpactonlabourproductivitycostsofcancerrelatedprematuremortalityineurope20182040
AT soerjomataramisabelle projectedimpactonlabourproductivitycostsofcancerrelatedprematuremortalityineurope20182040
AT sharplinda projectedimpactonlabourproductivitycostsofcancerrelatedprematuremortalityineurope20182040